The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
We have examined the toxicity and overall outcome of the Medical Research Council UKALL R1 protocol for 256 patients with relapsed childhood acute lymphoblastic leukaemia (ALL). Second remission was achieved in over 95% of patients. Two patients died during induction and seven patients died of resis...
Main Authors: | Lawson, SE, Harrison, G, Richards, S, Oakhill, A, Stevens, R, Eden, O, Darbyshire, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.
by: Harrison, G, et al.
Published: (2000) -
Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
by: Harrison, G, et al.
Published: (2000) -
Late relapsing childhood lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1997) -
Intraocular relapse of childhood acute lymphoblastic leukaemia.
by: Somervaille, T, et al.
Published: (2003) -
Late relapsing childhood acute lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1998)